The local medical landscape is excited with the introduction of retatrutide, a novel dual GIP and GLP-1 medication showing remarkable results in scientific trials for managing obesity. This medication https://socialrus.com/story25588905/retatrutide-australia-a-new-solution-for-obesity-treatment